Males With Psoriatic Arthritis Receiving Ixekizumab Reported Better Outcomes; Response Rates - Rheumatology Network

Understanding the differences between sexes regarding PsA treatment may change the management of PsA in male and female patients and improve outcomes.

Numerically larger improvements were seen in male patients with psoriatic arthritis (PsA) receiving ixekizumab when compared with females regarding remission, the American College of Rheumatology 20%… [+3716 chars]

full article...